Fibroblast involvement in soft connective tissue calcification

Frontiers in Genetics

Volumn 4, Issue MAR, 2013, Pages

  Ronchetti, Ivonne ^a   Boraldi, Federica ^a   Annovi, Giulia ^a   Cianciulli, Paolo ^b   Quaglino, Daniela ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

Ectopic calcification; Elastin; Extracellular matrix; Fibroblasts; Mesenchymal stromal cells; PXE; PXE like disorders

Indexed keywords

EID: 84876176551     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00022     Document Type: Review

References (192)

1. Abatangelo, G.,Daga-Gordini, D., Garbin, G., and Cortivo, R. (1975). Calcium ion-binding study on alphaelastin. Biochim. Biophys. Acta 1974, 371,526-533.
2. Abedin, M., Tintut, Y., and Demer, L. L. (2004). Vascular calcification: mechanisms and clinical ramifications.Arterioscler.Thromb.Vasc. Biol. 24,1161-1170.
3. Aessopos, A., Farmakis, D., and Loukopoulos, D. (2002). Elastic tissue abnormalities in haemolytic syndromes. Eur. J. Clin. Invest. 39, 640-642.
4. Aessopos, A., Farmakis, D., Karagiorga, M., Rombos, I., and Loucopoulos, D. (1997). Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in beta-thalassemia patients. Stroke 28, 2421-2424.
5. Aessopos, A., Samarkos, M., Voskaridou, E., Papaioannou, D., Tsironi, M., Kavouklis, E., et al. (1998). Arterial calcifications in beta-thalassemia. Angiology 49, 137-143.
6. Aessopos, A., Savvides, P., Stamatelos, G., Rombos, I., Tassiopoulos, T., Karagiorga, M., et al. (1992). Pseudoxanthoma elasticum-like skin lesions and angioid streaks in betathalassemia. Am. J. Hematol. 41, 159-164.
7. Aessopos, A., Stamatelios, G., Savvids, P., Kavouklis, E., Gabriel, L., Rombos, I., etal. (1989). Angioid streaks in homozygous beta thalassemia. Am. J. Ophthalmol. 108, 356-359.
8. Annovazzi, L., Viglio, S., Gheduzzi, D., Pasquali-Ronchetti, I., Zanone, C., Cetta, G., etal. (2004). High levels of desmosines in urine and plasma of patients with pseudoxanthoma elasticum. Eur. J. Clin. Invest. 34,156-164.
9. Arseculeratne, G., Evans, A. T., and Morley, S. M. (2006). Calciphylaxisatopical overview. J. Eur. Acad. Dermatol. Venereol. 20, 493-502.
10. Baccarani-Contri, M., Bacchelli, B., Boraldi, F., Quaglino, D., Taparelli, F., Carnevali, E., etal. (2001). Characterization of pseudoxanthomalke lesions in the skin of patients with beta-thalassemia. J. Am. Acad. Dermatol. 44,33-39.
11. Baccarani-Contri, M., Vincenzi, D., Cicchetti, F., Mori, G., and Pasquali-Ronchetti, I. (1994). Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elastic patients. Eur. J. Histochem. 38,111-123.
12. Bell, J. R., Boohan, R. C., Jones, J. H., and Moore,R. M. (1974).A synthetic polypeptide related to elastin and its interaction with calcium ions. Int. J. Pept. Protein Res. 6, 155-156.
13. Bercovitch, L., Martin, L., Chassaing, N., Hefferon, T. W., Bessis, D., Vanakker, O., etal. (2011). Acquired pseudoxanhoma elasticum presenting after liver transplantation. J. Am. Acad. Dermatol. 64,873-878.
14. Berenson, G. S., Radhakrishnamurthy, B., Srinivasan, S. R., Vijayagopal, P., and Dalferes, E. R. (1985). Proteoglycans and potential mechanisms related to atherosclerosis. Ann. N. Y. Acad. Sci. 454,69-78.
15. Bergen, A. A., Plomp, A. S., Schuurman, E. J., Terry, S., Breuning, M., Dauwerse, H., et al. (2000). Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet. 25, 228-231.
16. Black, A. S., and Kanat, I. O. (1985). A review of soft tissue calcifications. J. Foot Surg. 24,243-250.
17. Boraldi, F., Annovi, G., Carraro, F., Naldini, A., Tiozzo, R., Sommer, P., etal. (2007). Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach. Biochim. Biophys. Acta 1774, 14021413.
18. Boraldi, F., Annovi, G., Guerra, D., Paolinelli-DeVincenzi, C., Garcia-Fernandez, M. I., Panico, F., etal. (2009). Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in thepathogenesisof pseudoxanthoma elasticum. Proteomics Clin. Appl. 3, 1084-1098.
19. Boraldi, F., Annovi, G., Vermeer, C., Schurgers, L., Trenti, T., Tiozzo, R., etal. (in press). Matrix Gla Protein and alkaline phosphatase are differently motulated in human dermal fibroblasts from PXE patients and controls. J. Invest. Dermatol.doi: 10.1038/jid.2012.460 [Epub ahead of print].
20. Boraldi, F., Paolinelli, C., Garcia-Fernandez, M. I., Annovi, G., Quaglino,D.,Tiozzo,R.,etal. (2008). Comparison of fibroblasts from patientsaffectedbypseudoxanthoma elasticum(PXE)orby β-Thalassemia with (β-Thal-PXE+) and without PXE-like clinical manifestations (βThal-PXE-). Am. J. Pathol. 173,S11
21. Boraldi, F., Quaglino, D., Croce, M. A., Garcia-Fernandez, M. I., Tiozzo, R., Gheduzzi, D., etal. (2003). Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients. Matrix Biol. 22, 491-500.
22. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M. D., Del Vecchio, G. C., etal. (2004). Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89, 11871193.
23. Borst, P., van de Wetering, K., and Schlingemann, R. (2008). Does the absence of ABCC6 (multidrug resistance protein 6)in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 7, 1575-1579.
24. Boskey, A. L., Maresca, M., Ullrich, W., Doty, S. B., Butler, W. T., and Prince, C. W. (1993). Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatingel. Bone Miner. 22, 147-159.
25. Boskey, A. L., Spevak, L., Doty, S. B., and Rosenberg, L. (1997). Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite Ronchetti etal. Fibroblasts in ectopic calcifications formation in a gelatin gel. Calcif. Tissue Int. 61,298-305.
26. Boström, K., Watson, K. E., Horn, S., Wortham, C., Herman, I. M., and Demer, L. L. (1993). Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91,1800-1809.
27. Boulman, N., Slobodin, G., Rozenbaum,M.,andRosner,I. (2005). Calcinosis in rheumatic diseases. Semin. Arthritis Rheum. 34,805-812.
28. Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature 423, 337-342.
29. Brampton, C.,Yamaguchi,Y.,Vanakker, O.,Van Laer,L.,Chen,L.H.,Thakore, M., etal. (2011). Vitamin K does not prevent soft tissue mineralization in a mouse model of pseudoxanthoma elasticum. Cell Cycle 10, 1810-1820
30. Brenner, B. (2000). Hereditary deficiency of vitamin K-dependent coagulationfactors.Thromb.Haemost.84, 935-936.
31. Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., etal. (1998). Osteoprotegerindeficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268.
32. Bunda, S., Kaviani, N., and Hinek, A. (2005). Fluctuations of intracellular iron modulate elastin production. J. Biol. Chem. 280,2341-2351.
33. Buranasinsup, S., Sila-Asna, M., Bunyaratvej, N., and Bunyaratvej, A. (2006). In vitro osteogenesis from human skin-derived precursor cells. Dev. Growth Differ. 48,263-269.
34. Cancela, M. L., Conceição, N., and Laizé, V. (2012). Gla-rich protein, a new player in tissue calcification? Adv. Nutr. 3, 174-181.
35. Chan, A. C., Chow, C. K., and Chiu, D. (1999).Interaction of antioxidants and their implication in genetic anemia. Proc. Soc. Exp. Biol. Med. 222, 274-282.
36. Chang,H.Y.,Chi,J. T.,Dudoit,S.,Bondre, C.,Van de Rijn, M., Botstein, D., et al. (2002). Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 99,12877-12882.
37. Chen,J. H.,and Simmons,C.A. (2011). Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ. Res. 108,1510-1524.
38. Cherchi, G. M., Coinu, R., Depuro, P., Formato, M., Sanna, G., Timore, M., et al. (1990). Structural and functional modifications of human aorta proteoglycans in atherosclerosis. Matrix 10,362-372.
39. Cho, H. J., Cho, H. J., and Kim, H. S. (2009). Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr. Atheroscler. Rep. 11,206-213.
40. Cianciulli, P., Sorrentino, F., Maffei, L., Amadori, S., Cappabianca, M. P., Foglietta, E., et al. (2002). Cardiovascular involvement in thalassemic patients with pseudoxanthoma elasticum-like skin lesions: a long term follow-up study. Eur. J. Clin. Invest. 32, 600-606.
41. Cighetti, G., Duca, L., Bortone, L., Sala, S., Nava, I., Fiorelli, G., et al. (2002). Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur. J. Clin. Invest. 32, 55-60.
42. Collett,G.D.,andCanfield,A.E. (2005). Angiogenesis and pericytes in the initiation of ectopic calcification. Circ. Res. 96,930-938.
43. Contri, M., Fornieri, C., and Ronchetti, I. (1985). Elastin-proteoglycans association revealed by cytochemical methods. Connect. Tissue Res. 13, 237-249.
44. Cox, B. A., Starcher, B. C., and Urry, D. W. (1975). Scanning electron microscopy and electron probe microanalysis of calcified alphaelastin coacervates. Calcif. Tissue Res. 17, 219-227.
45. Cranenburg, E. C., VanSpaendonck-Zwarts, K. Y., Bonafe, L., Mittaz Crettol, L., Rodiger, L. A., Dikkers, F. G., et al. (2011). Circulating matrix γ-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome. J. Thromb. Haemost. 9, 1225-1235.
46. Davies, C. A., Jeziorska, M., Freemont, A. J., and Herrick, A. L. (2006). Expression of osteonectin and matrix gla protein in scleroderma patients with and without calcinosis. Rheumatology 45, 1349-1355.
47. De Boussac,H.,Ratajewski,M.,Sachrajda, I., Köblös, G., Tordai,A., Pulaski, L., et al. (2010). The ERK1/2hepatocyte nuclear factor 4α axis regulates human ABCC6 gene expression in hepatocytes. J. Biol. Chem. 285, 22800-22808.
48. Díaz-Flores,L.,Gutiérrez,R.,Varela,H., Rancel, N., and Valladares, F. (1991). Microvascular pericytes: a review of their morphological and functional characteristics. Histol. Histopathol. 6, 269-286.
49. Diekmann, U., Zarbock, R., Hendig, D., Szliska, C., Kleesiek, K., and Gotting, C. (2009). Elevated circulating levels of matrix metalloproteinases MMP2 and MMP9 in pseudoxanthoma elasticum patients. J. Mol. Med. 87, 965-970.
50. Doherty, M. J., and Canfield, A. E. (1999). Gene expression during vascular pericyte differentiation. Crit. Rev. Eukaryot. Gene Expr. 9,1-17.
51. El-Abbadi, M. M., Pai, A. S., Leaf, E. M., Yang, H. Y., Bartley, B. A., Quan, K. K., etal. (2009). Phosphate feeding induces arterial medial calcification in uremic mice: role of serumphosphorus,fibroblastgrowth factor-23, and osteopontin. Kidney Int. 75,1297-1307.
52. Fabbri, E., Forni, G. L., Guerrini, G., and Borgna-Pignatti, C. (2009). Pseudoxanthoma elasticum-like syndromes and thalassemia: an update. Dermatol. OnLine J. 15, 7.
53. Ganss, B., Kim, R. H., and Sodek, J. (1999). Bone sialoprotein. Crit. Rev. Oral Biol. Med. 10,79-98.
54. Garcia-Fernandez, M. I., Gheduzzi, D., Boraldi, F., Paolinelli, C. D., Sanchez, P., Valdivielso, P., etal. (2008). Parametersof oxidativestress are present in the circulation of PXE patients.Biochim.Biophys.Acta1782, 474-481.
55. Gheduzzi, D., Boraldi, F., Annovi, G., DeVincenzi, C. P., Schurgers, L. J., Vermeer, C., etal. (2007). Matrix gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab. Invest. 87,998-1008.
56. Gheduzzi, D., Guerra, D., Bochicchio, B., Pepe, A., Tamburo, A. M., Quaglino, D., et al. (2005). Heparan sulphate interacts with tropoelastin, with some tropoelastin peptides and is present in human dermis elastic fibers. Matrix Biol. 24, 15-25.
57. Gheduzzi, D., Sammarco, R., Quaglino, D., Bercovitch, L., Terry, S., Taylor, W., etal. (2003). Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum. Ultrastruct. Pathol. 27, 375-384.
58. Giachelli, C. M. (2001). Ectopic calcification: new concepts in cellular regulation. Z. Kardiol. 90,31-37.
59. Giachelli, C. M., Bae, N., Almeida, M., Denhardt, D. T., Alpers, C. E., and Schwartz, S. M. (1993). Osteopontin is elevated during neointima formation in rat arteries and is a novel componentof human atherosclerotic plaques. J. Clin. Invest. 92, 16861696.
60. Giachelli, C. M., and Steitz, S. (2000). Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 19,615-622.
61. Gibson, J. M., Chaudhuri, P. R., and Rosenthal, A. R. (1983). Angioid streaks in a case of beta thalassaemia major. Br. J. Ophthalmol. 67, 29-31.
62. Goldberg, M. F., Charache, S., and Acacio, I. (1971). Ophthalmologic manifestations in sickle cell thalassemia. Arch. Intern. Med. 128,33-39.
63. Golub, E. E. (2011). Biomineralization and matrix vesicles in biology and pathology. Semin. Immunopathol. 33, 409-417.
64. Gordon, S. G., Hinkle, L. L., and Shaw, E. (1983). Cysteine protease characteristics of the proteoglycanase activity from normal and pseudoxanthoma elasticum (PXE) fibroblasts. J. Lab. Clin. Med. 102, 400-410.
65. Gordon, S. G., Overland, M., and Foley, J. (1978). Evidence for increased protease activity secreted from cultured fibroblasts from patients with pseudoxanthoma elasticum. Connect. Tissue Res. 6, 61-68.
66. Gorgels,T.G.,Waarsing,J.H.,Herfs,M., Versteeg, D., Schoensiegel, F., Sato, T., et al. (2011). Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum. J. Mol. Med. 89,1125-1135.
67. Götting, C., Adam, A., Szliska, C., and Kleesiek,K. (2008). CirculatingP-,Land E-selectins in pseudoxanthoma elasticum patients. Clin. Biochem. 41, 368-374.
68. Götting, C., Hendig, D., Adam, A., Schön, S., Schulz, V., Szliska, C., etal. (2005). Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis. J. Mol. Med. 83,984-992.
69. Gundberg,C. M.,Lian,J. B.,and Booth, S. L. (2012). Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv. Nutr. 3,149-157.
70. Hamlin, N., Beck, K., Bacchelli, B., Cianciulli, P., Pasquali-Ronchetti, I., and Le Saux, O. (2003). Acquired pseudoxanthoma elasticum-like syndrome in beta-thalassemia patients. Br. J. Haematol. 122, 852-854.
71. Handford,P.A. (2000).Fibrillin-1,acalcium binding protein of extracellular matrix. Biochim. Biophys. Acta 1498, 84-90.
72. Hanley, M. E., and Repine, J. E. (1993). Elastase and oxygen radicals: synergistic interactions. Agents Actions Suppl. 42,39-47.
73. Heiss, A., DuChesne, A., Denecke, B., Grötzinger, J., Yamamoto, K., Renné, T., etal. (2003). Structural basis of calcification inhibition by alpha2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.J.Biol. Chem. 278,13333-13341.
74. Hendig, D., Adam, A., Zarbock, R., Szliska, C., Kleesiek, K., and Götting, C. (2008a). Elevated serum levels of intercellular adhesion molecule ICAM-1 in Pseudoxanthoma elasticum. Clin. Chim. Acta 394, 54-58
75. Hendig, D., Zarbock, R., Szliska, C., Kleesiek, K., and Gotting, C. (2008b). The local calcification inhibitor matrix gal protein in pseudoxanthoma elasticum. Clin. Biochem. 41,407-412.
76. Hendig, D., Arndt, M., Szliska, C., Kleesiek, K., and Götting, C. (2007). SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin. Chem. 53,829-836
77. Hendig, D., Schulz, V., Arndt, M., Szliska, C., Kleesiek, K., and Gotting, C. (2006). Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin. Chem. 52, 227-234.
78. Hershko, C., Konijn, A. M., and Link, G. (1998). Iron chelators for thalassaemia. Br. J. Haematol. 101, 399-406.
79. Ho,A.M.,Johnson,M.D.,andKingsley, D. M. (2000). Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289,265-270.
80. Hocking, A. M., Shinomura, T., and McQuillan,D.J. (1998).Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 17,1-19.
81. Hoff, N. P., and Homey, B. (2011). Calciphylaxis. Pathogenesis and therapy. Hautarzt 62, 509-515.
82. Honjo, S., Yokote, K., Fujimoto, M., Takemoto, M., Kobayashi, K., Maezawa, Y., etal. (2008). Clinical outcome and mechanism of soft tissue calcification in Werner syndrome. Rejuvenation Res. 11,809-819.
83. Hosaka, N., Mizobuchi, M., Ogata, H., Kumata,C.,Kondo,F.,Koiwa,F.,etal. (2009). Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells. Calcif. Tissue Int. 85, 523-529.
84. Hunter, G. K. (1991). Role of proteoglycan in the provisionalcalcification of cartilage. A review and reinterpretation. Clin. Orthop. Relat. Res. 262, 256-280.
85. Jahnen-Dechent, W., Schäfer, C., Ketteler, M., and McKee, M. D. (2008). Mineral chaperones:a role for fetuinA and osteopontin in the inhibition and regression of pathologic calcification. J. Mol. Med. 86,379-389.
86. Jiang, Q., Dibra, F., Lee, M. D., Oldenburg, R., and Uitto, J. (2010). Overexpression of fetuin-a counteracts ectopic mineralization in a mouse model of pseudoxanthoma elasticum (abcc(-/-)).J.Invest.Dermatol.130, 1288-1296.
87. Jiang, Q., Li, Q., Grand-Pierre, A. E., Schurgers, L. J., and Uitto, J. (2011). Administration of vitaminK does not counteract the ectopic mineralization of connective tissues in Abcc6 (-/-) mice, a model for pseudoxanthoma elasticum. Cell Cycle 10,701-707.
88. Jono, S., Ikari, Y., Shioi, A., Mori, K., Miki, T., Hara, K., et al. (2002). Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106,1192-1194.
89. Jono, S., Peinado, C., and Giachelli, C. M. (2000). Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J. Biol. Chem. 275, 20197-20203.
90. Kim, Y. J., Lee, M. H., Wozney, J. M., Cho, J. Y., and Ryoo, H. M. (2004). Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J. Biol. Chem. 279, 50773-50780.
91. Kinsella,F. P.,and Mooney,D. J. (1988). Angioid streaks in beta thalassaemia minor. Br. J. Ophthalmol. 72, 303-304.
92. Kornak, U. (2011). Animal models with pathological mineralization phenotypes. Joint Bone Spine 78, 561-567.
93. Lau, W. L., Festing, M. H., and Giachelli, C. M. (2010). Phosphate and vascular calcification: emerging role of the sodium-dependent phosphate co-transporter PiT-1. Thromb. Haemost. 104,464-470.
94. LeBoulanger,G.,Labrèze,C.,Croué,A., Schurgers, L. J., Chassaing, N., Wittkampf, T., etal. (2010). An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am.J.Med. Genet. 152A,118-123.
95. Le Saux, O., Bunda, S., VanWart, C. M., Douet, V., Got, L., Martin, L., etal. (2006). Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J. Invest. Dermatol. 126, 14971505.
96. Le Saux, O., Urban, Z., Tschuch, C., Csiszar, K., Bacchelli, B., Quaglino, D., etal. (2000). Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat. Genet. 25, 223-227.
97. Li, J., Zhang, B., Huang, Z., Wang, S., Tang, C., and Du, J. (2004). Taurinepreventsbeta-glycerophosphateinduced calcification in cultured rat vascular smooth muscle cells. Heart Vessels 19,125-131.
98. Li, Q., Jiang, Q., Schurgers, L. J., and Uitto, J. (2007). Pseudoxanthoma elasticum: reduced gamma-glutamyl carboxylation of matrix gla protein in a mouse model (Abcc6 -/-). Biochem. Biphys. Res. Commun. 364, 208-213.
99. Li, Q., Schumacher, W., Jablonski, D., Siegel, D., and Uitto, J. (2012). Cutaneous features of pseudoxanthoma elastiucm in a patient with generalized arterial calcification of infancy due to a homologous missense mutation in the ENPP1 gene. Br. J. Dermatol. 166, 1107-1111.
100. Li, X., Yang, H. Y., and Giachelli, C. M. (2008). BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199,271-277.
101. Li, Z., Wang, Y., and Vanhoutte, P. M. (2011). Upregulation of heme oxygenase 1 by hemin impairs endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Hypertension 58,926-934.
102. Lindner, D., Zietsch, C., Becher, P. M., Schulze, K., Schultheiss, H. P., Tschöpe, C., etal. (2012). Differential expression of matrix metalloproteases in human fibroblasts with different origins. Biochem. Res. Int. 2012, 875742.
103. Liu, Y., and Shanahan, C. M. (2011). Signalling pathways and vascular calcification. Front. Biosci. 16, 13021314.
104. Livrea, M. A., Tesoriere, L., Pintaudi, A. M., Calabrese, A., Maggio, A., Freisleben, H. J., etal. (1996). Oxidative stress and anti-oxidant status in beta-thalasssemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 88, 3608-3614.
105. Long,M.M.,Onishi,T.,andUrry,D.W. (1975). Ion binding by hexapeptide of elastin. Arch. Biochem. Biophys. 166,187-192.
106. Long,M.M.,andUrry,D.W. (1981).On the molecular mechanisms of elastic fiber calcification. Trans. Am. Soc. Artif. Intern. Organs 27,690-696.
107. Maccari,F.,andVolpi,N. (2008). Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum. Int. J. Dermatol. 47,1024-1027.
108. Madhavan,M. (1977).Glycosaminoglycans, elastin and collagen content of normal adult human aorta at different anatomical levels. Indian J. Exp. Biol. 15,132-133.
109. Martin, L., Douet, V., VanWart, C. M., Heller, M. B., and Le Saux, O. (2011). A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression. Am. J. Pathol. 178,774-783.
110. McMillan, C. W., and Roberts, H. R. (1966). Congenital combined deficiency of coagulation factors II, VII, IX and X. Report of a case. N. Engl.J.Med. 274,1313-1315.
111. Mendes,S.C.,Tibbe,J.M.,Veenhof,M., Both, S., Oner, F. C., van Blitterswijk, C. A., etal. (2004). Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J. Mater. Sci. Mater. Med. 15,1123-1128.
112. Meral, A., Tuncel, P., Sürmen-Gür, E., Ozbek, R., Oztürk, E., and Günay, U. (2000). Lipid peroxidation and antioxidant status in betathalassemia. Pediatr. Hematol. Oncol. 17, 687-693.
113. Mochida, Y., Parisuthiman, D., Pornprasertsuk-Damrongsri, S., Atsawasuwan, P., Sricholpech, M., Boskey, A. L., etal. (2009). Decorin modulates collagen matrix assembly and mineralization. Matrix Biol. 28, 44-52.
114. Moe, S. M. (2012). Klotho: a master regulator of cardiovascular disease? Circulation 125,2181-2183.
115. Molinari-Tosatti, M. P., Galzigna, L., Moret,V.,andGotte,L. (1968). Some features of the binding of calcium ions to elastin. Calcif. Tissue Res. 2, S88.
116. Moore, A., Merad-Boudia, M., Lehalle, D., Massrieh, W., Derjuga, A., and Blank,V. (2006).Regulationofglobin gene transcription by heme in erythroleukemia cells: analysis of putative heme regulatory motifs in the p45 NF-E2 transcription factor. Antioxid. Redox Signal. 8,68-75.
117. Morena, M., Terrier, N., Jaussent, I., Leray-Moragues, H., Chalabi, L., Rivory, J. P., etal. (2006). Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J. Am. Soc. Nephrol. 17,262-270.
118. Munroe, P. B., Olgunturk, R. O., Fryns, J. P.,Van Maldergem,L.,Ziereisen,F., Yuksel, B., etal. (1999). Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat. Genet. 21, 142-144.
119. Nagpal, C. K., Asdourian, G., Goldbaum, M., Apple, D., and Goldberg, F. M. (1976). Angioid streaks and sickle haemoglobinopathies. Br. J. Ophthalmol. 60,31-34.
120. Neogi, T., Booth, S. L., Zhang, Y. Q., Jacques,P.F.,Terkeltaub,R.,Aliabadi, P.,etal. (2006). Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 54, 1255-1261.
121. Nitschke, Y., Baujat, G., Botschen, U., Wittkampf, T., du Moulin, M., Stella, J., et al. (2012). Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am. J. Hum. Genet. 90, 25-39.
122. O'Donnell, B. F., Powell, F. C., O'Loughlin, S., and Acheson, R. W. (1991). Angioid streaks in beta thalassemia minor. Br. J. Ophthalmol. 75,639.
123. Okawa, A., Nakamura, I., Goto, S., Moriya, H., Nakamura, Y., and Ikegawa, S. (1998). Mutations in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat. Genet. 19, 271-273.
124. Orimo, H. (2010). The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J. Nippon Med. Sch. 77,4-12
125. O'Young, J., Liao, Y., Xiao, Y., Jalkanen, J., Lajoie, G., Karttunen, M., etal. (2011). Matrix gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J. Am. Chem. Soc. 133, 18406-18412.
126. Pai, A., Leaf, E. M., El-Abbadi, M., and Giachelli, C. M. (2011). Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am. J. Pathol. 178, 764-773.
127. Palaniswamy, C., Sekhri, A., Aronow, W. S., Kalra, A., and Peterson, S. J. (2011). Association of warfarin use with valvular and vascular calcification: a review. Clin. Cardiol. 34, 74-81.
128. Park, S. A., Kim, I. A., Lee, Y. J., Shin, J. W., Kim, C. R., Kim, J. K., etal. (2006). Biological responses of ligament fibroblasts and gene expression profiling on micropatterned silicone substrates subjected to mechanical stimula. J. Biosci. Bioeng. 102, 402-412.
129. Pasquali-Ronchetti, I., Baccarani-Contri, M., Pincelli, C., and Bertazzoni, G. M. (1986). Effect of selective enzymatic digestions on skin biopsies from pseudoxanthoma elasticum; an ultrastructural study. Arch. Dermatol. Res. 278, 386-392.
130. Pasquali-Ronchetti, I., Bressan, G. M., Fornieri, C., Baccarani-Contri, M., Castellani, I., and Volpin, D. (1984). Elastin fiber-associated glycosaminoglycans in beta-aminopropionitrile induced lathyrism. Exp. Mol. Pathol. 40,235-245.
131. Pasquali-Ronchetti, I., Garcia-Fernandez, M. I., Boraldi, F., Quaglino, D., Gheduzzi, D., Paolinelli-DeVincenzi, C., et al. (2006). Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible rol in the pathogenesis of clinical manifestations. J. Pathol. 208,54-61
132. Passi, A., Albertini, R., Baccarani-Contri, M., DeLuca, G., DePaepe, A., Pallavicini, G., et al. (1996). Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum. Cell Biochem. Funct. 14,111-120.
133. Passi, A., Albertini, R., Campanari, F., and DeLuca, G. (1997). Modifications of proteoglycans extracted from monolayer cultures of young and senescent human skin fibroblasts. FEBS Lett. 420, 175-178.
134. Paton, D. (1959). Angioid streaks and sickle cell anemia: a report of two cases.Arch.Ophthalmol.62,852-858
135. Pendleton, A., Johnson, M. D., Hughes, A., Gurley, K. A., Ho,A. M., Doherty, M.,et al. (2002).Mutations in ANKH cause chondrocalcinosis.Am.J.Hum. Genet. 71,933-940.
136. Perrotta, I., Russo, E., Camastra, C., Filice, G., DiMizio, G., Colosimo, F., etal. (2011). New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastrucural study withliteraturereview. Histopathology 59,504-513.
137. Price, P. A., Chan, W. S., Jolson, D. M., and Williamson, M. K. (2006). The elastic lamellae of devitalized arteries calcify when incubated in serum. Evidence for a serum calcifying factor. Arterioscler. Thromb. Vasc. Biol. 26,1079-1085.
138. Price, P. A.,Williamson, M. K., Nguyen, T. M.,and Than,T. N. (2004). Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J. Biol. Chem. 279, 15941600.
139. Pugashetti, R., Shinkai, K., Ruben, B. S., Grossman, M. E., Maldonado, J., and Fox, L. P. (2011). Calcium may preferentially deposit in areas of elastic tissue damage. J. Am. Acad. Dermatol. 64,296-301.
140. Qu,X.,Jimenez-Vergara,A. C.,Munoz-Pinto, D. J., Ortiz, D., McMahon, R. E., Cristancho, D., et al. (2011). Regulationof smooth muscle cell phenotype by glycosaminoglycan identity. Acta Biomater. 7,1031-1039.
141. Quaglino, D., Boraldi, F., Annovi, G., and Ronchetti, I. (2011). "The multifaceted complexity of genetic diseases:a lesson from pseudoxanthoma elasticum," in Advances in the Study of Genetic Disorders, ed. K. Ikehara (Rijeka,Croazia: InTech) 289-318.
142. Quaglino, D., Boraldi, F., Barbieri, D., Croce, A., Tiozzo, R., and Pasquali-Ronchetti, I. (2000). Abnormal phenotype of in vitro dermal fibroblasts from patients with Pseudoxanthoma elasticum (PXE). Biochim. Biophys. Acta 1501, 51-62.
143. Quaglino, D., Sartor, L., Garbisa, S., Boraldi, F., Croce, A., Passi, A., etal. (2005). Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim. Biophys. Acta 1741,42-47.
144. Rajachar, R. M., Tung, E., Truong, A. Q., Look, A., and Giachelli, C. M. (2009). Role of carbonic anhydrase II in ectopic calcification. Cardiovasc. Pathol. 18, 77-82.
145. Rath, N., Bhardwaj, A., Kar, H. K., Sharma, P. K., Bharadwaj, M., and Bharija, S. C. (2005). Penicillamine induced pseudoxanthoma elasticum with elastosis perforans serpiginosa. Indian J. Dermatol. Venerol. Leprol. 71,182-185.
146. Rees, S. G., Hughes Wassell, D. T., Waddington, R. J., and Embery, G. (2001). Interaction of bone proteoglycans and proteoglycan components with hydroxyapatite. Biochim. Biophys. Acta 1568, 118-128.
147. Ringpfeil, F., Lebwohl, M. G., Christiano, A. M., and Uitto, J. (2000). Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. U.S.A. 97,6001-6006.
148. Rinn, J. L., Wang, J. K., Liu, H., Montgomery, K., van de Rijn, M., and Chang, H. Y. (2008). A systems biology approach to anatomic diversity of skin. J. Invest. Dermatol. 128, 776-782.
149. Rizzoli, R., and Bonjour, J. P. (1998). Calciotropic hormones and integrated regulation of calcemia and calcium balance. Rev. Prat. 48, 11781184.
150. Roach, H. I. (1994). Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol. Int. 18, 617-628.
151. Román-García, P., Carrillo-López, N., Fernández-Martín, J. L., Naves-Díaz, M., Ruiz-Torres, M. P., and Cannata-Andía,J. B. (2010). High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 46,121-128.
152. Rosen, V. (2009). BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev. 20, 475-480.
153. Rutsch, F., Ruf, N., Vaingankar, S., Toliat, M. R., Suk, A., Höhne, W., etal. (2003). Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat. Genet. 34, 379-381.
154. Schinke, T., Amendt, C., Trindl, A., Pöschke, O., Müller-Esterl, W., and Jahnen-Dechent, W. (1996). The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J.Biol. Chem. 271,20789-20796.
155. Schlieper, G., Westenfeld, R., Brandenburg, V., and Ketteler, M. (2007). Inhibitors of calcification in blood and urine. Semin. Dial. 20,113-121
156. Schön, S., Schulz, V., Prante, C., Hendig, D., Szliska, C., Kuhn, J., et al. (2006). Polymorphisms in the xylosyltrasferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course. J. Med. Genet. 43,745-749.
157. Schurgers, L. J., Spronk, H. M., Skepper, J. N., Hackeng, T. M., Shanahn, C. M., Vermeer, C., et al. (2007). Post-translational modifications regulate matrix gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J. Thromb. Haemost. 5,2503-2511.
158. Schwartz, E., Thieberg, M., Cruickshank,F.A.,and Lebwohl,M. (1991). Elastase digestion of normal and pseudoxanthoma elasticum lesional skin elastins. Exp. Mol. Pathol. 55, 190-195.
159. Shanahan, C. M., Proudfoot, D., Farzaneh-Far, A., and Weissberg, P. L. (1998). The role of Gla proteins in vascular calcification. Crit. Rev. Eukaryot. Gene Expr. 8,357-375.
160. Shao, J. S., Cheng, S. L., Sadhu, J., and Towler, D. A. (2010). Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55, 579592.
161. Shen, Q., Little, S. C., Xu, M., Haupt, J., Ast, C., Katagiri, T., etal. (2009). The fibrodysplasia ossificans progressiva R206HACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J. Clin. Invest. 119, 3462-3472.
162. Shin, V., Zebboudj, A. F., and Boström, K. (2004). Endothelial cells modulate osteogenesis in calcifying vascular cells. J. Vasc. Res. 41,193-201.
163. Shroff, R. C., and Shanahan, C. M. (2007). The vascular biology of calcification. Semin. Dial. 20,103-109
164. Simionescu, A., Simionescu, D. T., and Vyavahare, N. R. (2007). Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am. J. Pathol. 171, 116-123.
165. Starcher, B. C., and Urry, D. W. (1973). Elastin coacervates as a matrix for calcification. Biochem. Biophys. Res. Commun. 53,210-216.
166. StHilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., et al. (2011). NT5E mutations and arterial calcifications. N.Engl. J.Med. 364, 432-442.
167. Suerig, K.C., and Siefert, F.E. (1964). Pseudoxanthoma elasticum and sickle cell anemia. Arch. Intern. Med. 113, 135-141.
168. Suzuki, A., Ghayor, C., Guicheux, J., Magne, D., Quillard, S., Kakita, A., et al. (2006). Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblastlike cells. J. Bone Miner. Res. 21, 674-683.
169. Takada, T., Katagiri, T., Ifuku, M., Morimura, N., Kobayashi, M., Hasegawa, K., etal. (2003). Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278, 4322943235.
170. Tamburro, A. M., Guantieri, V., Daga-Gordini, D., and Abatangelo, G. (1977). Conformational transitions of alpha elastin. Biochim. Biophys. Acta 492,370-376.
171. Terkeltaub, R. A. (2001). Inorganic pyrophosphate generation and disposition in pathophysiology. Am. J. Physiol. Cell Physiol. 281,C1-C11.
172. Theuwissen, E., Smit, E., and Vermeer, C. (2012). The role of vitamin K in soft-tissue calcification. Adv. Nutr. 3, 166-173.
173. Tiozzo-Costa, R., Baccarani-Contri, M., Cingi, M. R., Pasquali-Ronchetti, I., Salvini, R., Rindi, S., etal. (1988). Pseudoxanthoma elasticum (PXE): ultrastructural and biochemical study on proteoglycan and proteoglycan associated material produced by skin fibroblasts in vitro. Coll. Relat. Res. 8,49-64.
174. Truter, S., Rosenbaum-Fiedler, J., Sapadin,A.,and Lebwohl,M. (1996). Calcification of elastic fibers in pseudoxanthoma elasticum. Mt. Sinai J. Med. 63, 210-215.
175. Tsomi, K., Karagiorga-Lagana, M., Karabatsos, F., Fragodimitri, C., Van Vliet-Konstantinidou, C., Premetis, E., etal. (2001). Arterial elasorrhexis in beta-thalassemia intermedia,sickle cell thalassemia and hereditary spherocytosis. Eur. J. Haematol. 67, 135-141.
176. Uchimura, E., Machida, H., Kotobuki, N., Kihara, T., Kitamura, S., Ikeuchi, M.,etal. (2003). In-situ visualization and quantification of mineralization of cultured osteogenetic cells. Calcif. Tissue 73, 575-583.
177. Urry, D. W., Trapane, T. L., and Venkatachalam, C. M. (1982). Calcium binding to a calcifiable matrix: 43Ca NMR binding studies on the polypentapeptide of elastin. Calcif. Tissue Int. 34,S41-S46.
178. Vanakker, O. M., Leroy, B. P., Schurgers, L. J., Vermeer, C., Coucke, P. J., and DePaepe, A. (2011). Atypical presentation of pseudoxanthoma elasticum with abdominal cutis laxa: evidence for a spectrum of ectopic calcification disorders? Am.J.Med.Genet. 155A, 2855-2859.
179. Vanakker, O. M., Martin, L., Gheduzzi, D., Leroy, B. P., Loeys, B., Guerci,V.I.,et al. (2007).Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate entity. J. Invest. Dermatol. 127, 581-587.
180. Vanakker, O. M., Martin, L., Schurgers, L. J., Quaglino, D., Costrop, L., Vermeer, C., etal. (2010). Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in PXE-like syndrome. Lab. Invest. 90,895-905.
181. Van Campenhout, A., and Golledge, J. (2009). Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204, 321-329.
182. Vattikuti, R., and Towler, D. A. (2004). Osteogenic regulation of vascular calcification: an early perspective. Am. J. Physiol. Endocrinol. Metab. 286, E686-E696.
183. Villa-Bellosta, R., Bogaert, Y. E., Levi, M., and Sorribas, V. (2007). Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler. Thromb. Vasc. Biol. 27,1030-1036.
184. Volpi,N.,and Maccari, F. (2006).Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum. Clin. Chim. Acta 370,196-200.
185. Wajih, N., Sane, D. C., Hutson, S. M., andWallin,R. (2004). The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.J.Biol.Chem.279,25276-25283
186. Wallin, R., Wajih, N., and Hutson, S. M. (2008). VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors. Vitam. Horm. 78, 227-246.
187. Yajima, T., Kumegawa, M., and Hiramatsu, M. (1984). Ectopic mineralization in fibroblast cultures. Arch. Histol. Jpn. 47,43-55.
188. Yao, Y., Jumabay, M., Wang, A., and Boström, K. I. (2011). Matrix Gla protein deficiency causes arteriovenous malformations in mice. J. Clin. Invest. 121,2993-3004.
189. Yu, F., Cui, Y., Zhou, X., Zhang, X., and Han, J. (2011). Osteogenic differentiation of human ligament fibroblasts induced by conditioned medium of osteoclast-like cells. Biosci. Trends 5,46-51.
190. Zarbock, R., Hendig, D., Szliska, C., Kleesiek, K., and Götting, C. (2007). Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin. Chem. 53,1734-1740.
191. Zarbock, R., Hendig, D., Szliska, C., Kleesiek, K., and Götting, C. (2010). Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum. Clin. Chim. Acta 411,1487-1490.
192. Zebboudj, A. F., Imura, M., and Boström,K. (2002).Matrix GLAprotein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem. 277,4388-4394.